Header Logo

Connection

Parameswaran Venugopal to Azacitidine

Back to Details
This is a "connection" page, showing publications Parameswaran Venugopal has written about Azacitidine.
Parameswaran Venugopal
Connection Strength
0.049
Azacitidine
  1. Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer. 2021 12 01; 127(23):4421-4431.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.